vs
monday.com Ltd.（MNDY）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
monday.com Ltd.的季度营收约是Royalty Pharma plc的1.1倍（$704.0M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 1.3%，领先33.1%）
monday.com是总部位于以色列特拉维夫的云平台服务商，2014年正式推出核心产品，支持用户自定义搭建应用及项目管理工具。公司2019年完成1.5亿美元融资，估值达19亿美元，2021年6月正式公开上市。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MNDY vs RPRX — 直观对比
营收规模更大
MNDY
是对方的1.1倍
$622.0M
净利率更高
RPRX
高出33.1%
1.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $704.0M | $622.0M |
| 净利润 | $9.4M | $214.2M |
| 毛利率 | 89.6% | — |
| 营业利润率 | -4.4% | 62.4% |
| 净利率 | 1.3% | 34.4% |
| 营收同比 | — | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | — | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MNDYRPRX
| Q4 25 | — | $622.0M | ||
| Q3 25 | $704.0M | $609.3M | ||
| Q2 25 | $453.0M | $578.7M | ||
| Q1 25 | $216.9M | $568.2M | ||
| Q4 24 | — | $593.6M | ||
| Q3 24 | $527.1M | $564.7M | ||
| Q2 24 | $337.9M | $537.3M | ||
| Q1 24 | $162.3M | $568.0M |
净利润MNDYRPRX
| Q4 25 | — | $214.2M | ||
| Q3 25 | $9.4M | $288.2M | ||
| Q2 25 | $21.4M | $30.2M | ||
| Q1 25 | $7.1M | $238.3M | ||
| Q4 24 | — | $208.2M | ||
| Q3 24 | $-14.2M | $544.0M | ||
| Q2 24 | $-21.7M | $102.0M | ||
| Q1 24 | $-14.7M | $4.8M |
毛利率MNDYRPRX
| Q4 25 | — | — | ||
| Q3 25 | 89.6% | — | ||
| Q2 25 | 89.6% | — | ||
| Q1 25 | 89.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 89.0% | — | ||
| Q2 24 | 89.2% | — | ||
| Q1 24 | 89.5% | — |
营业利润率MNDYRPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | -4.4% | 70.1% | ||
| Q2 25 | -0.7% | 36.3% | ||
| Q1 25 | -2.3% | 94.0% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | -7.1% | — | ||
| Q2 24 | -10.3% | 50.2% | ||
| Q1 24 | -14.0% | -13.0% |
净利率MNDYRPRX
| Q4 25 | — | 34.4% | ||
| Q3 25 | 1.3% | 47.3% | ||
| Q2 25 | 4.7% | 5.2% | ||
| Q1 25 | 3.3% | 41.9% | ||
| Q4 24 | — | 35.1% | ||
| Q3 24 | -2.7% | 96.3% | ||
| Q2 24 | -6.4% | 19.0% | ||
| Q1 24 | -9.0% | 0.8% |
每股收益（稀释后）MNDYRPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $0.23 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $1.0B | $9.7B |
| 总资产 | $1.7B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MNDYRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | $1.4B | $938.9M | ||
| Q2 25 | $1.7B | $631.9M | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | $1.1B | $950.1M | ||
| Q2 24 | $1.3B | $1.8B | ||
| Q1 24 | $1.1B | $843.0M |
总债务MNDYRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益MNDYRPRX
| Q4 25 | — | $9.7B | ||
| Q3 25 | $1.0B | $9.6B | ||
| Q2 25 | $1.2B | $9.5B | ||
| Q1 25 | $1.0B | $9.8B | ||
| Q4 24 | — | $10.3B | ||
| Q3 24 | $813.5M | $10.3B | ||
| Q2 24 | $910.1M | $9.8B | ||
| Q1 24 | $813.5M | $9.9B |
总资产MNDYRPRX
| Q4 25 | — | $19.6B | ||
| Q3 25 | $1.7B | $19.3B | ||
| Q2 25 | $2.0B | $18.3B | ||
| Q1 25 | $1.7B | $17.6B | ||
| Q4 24 | — | $18.2B | ||
| Q3 24 | $1.3B | $18.0B | ||
| Q2 24 | $1.5B | $17.7B | ||
| Q1 24 | $1.3B | $16.1B |
负债/权益比MNDYRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $234.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $224.6M | — |
| 自由现金流率自由现金流/营收 | 31.9% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | 25.02× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $608.3M | — |
8季度趋势，按日历期对齐
经营现金流MNDYRPRX
| Q4 25 | — | $827.1M | ||
| Q3 25 | $234.4M | $702.6M | ||
| Q2 25 | $147.7M | $364.0M | ||
| Q1 25 | $92.0M | $596.1M | ||
| Q4 24 | — | $742.5M | ||
| Q3 24 | $156.9M | $703.6M | ||
| Q2 24 | $90.3M | $658.2M | ||
| Q1 24 | $42.7M | $664.6M |
自由现金流MNDYRPRX
| Q4 25 | — | — | ||
| Q3 25 | $224.6M | — | ||
| Q2 25 | $141.8M | — | ||
| Q1 25 | $90.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $151.4M | — | ||
| Q2 24 | $85.6M | — | ||
| Q1 24 | $39.2M | — |
自由现金流率MNDYRPRX
| Q4 25 | — | — | ||
| Q3 25 | 31.9% | — | ||
| Q2 25 | 31.3% | — | ||
| Q1 25 | 41.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 28.7% | — | ||
| Q2 24 | 25.3% | — | ||
| Q1 24 | 24.1% | — |
资本支出强度MNDYRPRX
| Q4 25 | — | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 2.2% | — |
现金转化率MNDYRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 25.02× | 2.44× | ||
| Q2 25 | 6.91× | 12.06× | ||
| Q1 25 | 12.99× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MNDY
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
